サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1791541

バイオプロセスバッグの世界市場

Bioprocess Bags

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
バイオプロセスバッグの世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオプロセスバッグの世界市場は2030年までに116億米ドルに達する見込み

2024年に44億米ドルと推定されるバイオプロセスバッグの世界市場は、2024年から2030年にかけてCAGR 17.8％で成長し、2030年には116億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つである2Dバイオプロセスバッグは、CAGR 20.0%を記録し、分析期間終了時には66億米ドルに達すると予測されています。3Dバイオプロセスバッグ分野の成長率は、分析期間のCAGRで16.4％と推定されます。

米国市場は11億米ドル、中国はCAGR16.7%で成長すると予測

米国のバイオプロセスバッグ市場は、2024年に11億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは16.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.7%と15.1%と予測されています。欧州では、ドイツがCAGR約12.8%で成長すると予測されています。

世界のバイオプロセスバッグ市場- 主要動向と促進要因のまとめ

バイオプロセスバッグがバイオ医薬品・バイオテクノロジー分野に革命を起こす理由とは？

バイオプロセスバッグは現代のバイオ医薬品製造の要となり、医薬品製造における無菌性、効率性、拡張性を確保する上で重要な役割を果たしています。特殊なポリマーフィルムから作られるこれらのシングルユース・バイオプロセシングバッグは、細胞培養、発酵、培地保存、生物学的製品の輸送のための封じ込めソリューションとして機能します。モノクローナル抗体、ワクチン、遺伝子治療、個別化医療などの生物製剤の急速な拡大に伴い、高性能なバイオプロセスバッグの需要が急増しています。バイオ医薬品企業は、汚染リスクを排除し、運用コストを削減し、生産の柔軟性を高めるために、こうしたシングルユース・ソリューションの採用を増やしています。

従来のステンレス製バイオリアクターからシングルユースシステムへの移行が、バイオプロセスバッグの成長をさらに後押ししています。シングルユースのバイオプロセスバッグは、大掛かりな洗浄やバリデーションが必要な再利用システムとは異なり、オペレーションを合理化し、ダウンタイムを最小限に抑え、多品種生産施設での迅速な切り替えをサポートします。COVID-19ワクチンの需要の高まりや、細胞・遺伝子治療製造の進歩も、研究機関、受託製造機関（CMO）、バイオテクノロジー企業でのバイオプロセスバッグの採用を加速させています。バイオプロセスが進化し続ける中、バイオプロセスバッグは生物製剤製造における効率性、無菌性、費用対効果を最適化する上で重要な役割を果たすことになるでしょう。

技術革新はどのようにバイオプロセスバッグの性能を高めているのでしょうか？

材料科学、バリアプロテクション、バイオプロセス技術の著しい進歩により、バイオプロセスバッグの性能は大きく変化し、医薬品用途においてより信頼性が高く、効率的なものとなっています。この分野における最も注目すべき技術革新の一つは、耐久性、耐薬品性、ガス透過性制御を強化する多層ポリマーフィルムの開発です。ポリエチレン、エチレンビニルアルコール（EVOH）、ポリ塩化ビニル（PVC）から作られることが多いこれらの高性能フィルムは、溶出物、抽出物、微生物汚染に対して優れた保護を提供します。さらに、ガンマ線に安定した素材を使用することで、滅菌処理後もバイオプロセスバッグの完全性が維持され、重要な医薬品製造工程での使用性が向上しています。

バイオプロセスバッグ技術におけるもう一つの大きなブレークスルーは、リアルタイムモニタリングと自動化の統合です。内蔵センサーを備えたスマートバイオプロセスバッグは、pH、温度、溶存酸素、圧力レベルを追跡することができ、プロセス最適化のためのリアルタイムデータを提供します。この進歩は品質管理を強化し、バイオ医薬品製造におけるバッチ不良のリスクを低減します。さらに、無菌クイックコネクトシステムや無菌溶接技術など、バイオプロセス用バッグコネクターの技術革新は、無菌性を維持しながら流体移送効率を向上させています。細胞治療や遺伝子治療のアプリケーションなど、特定の生物製剤に合わせたカスタマイズされたバイオプロセスバッグの開発が進んでおり、最新のバイオプロセス環境におけるこれらのソリューションの汎用性がさらに拡大しています。

バイオプロセスバッグの成長を促進する市場動向は？

世界のバイオプロセスバッグ市場は、バイオ医薬品製造におけるシングルユース技術の採用増加により、大きな成長を遂げています。業界を形成する最も影響力のある動向の一つは、柔軟でモジュール化されたバイオプロセス設備へのシフトです。バイオ医薬品企業がより高い俊敏性と効率性を追求する中、シングルユースはモジュール式クリーンルーム設計やハイブリッド製造システムに組み込まれ、ステンレス鋼製設備への設備投資を削減しています。開発・製造受託機関（CDMO）への依存度が高まっていることも、市場拡大に寄与しています。CDMOは、スケーラブルでコスト効率に優れたシングルユース・バイオプロセシング・ソリューションを優先しているためです。

バイオプロセスバッグの需要を牽引するもう一つの重要な動向は、個別化医療、再生医療、細胞ベースの免疫療法を含む先端療法の台頭です。このような高価値の生物製剤では、無菌で汚染のない環境が最も重要であり、シングルユースのバイオプロセスバッグが保管や輸送に選ばれています。さらに、特にmRNAワクチンやウイルスベクターワクチンを中心としたワクチン製造の拡大により、迅速な生産スケーリングを可能にするシングルユース・バイオプロセス・ソリューションの需要が高まっています。また、環境に優しいバイオプロセスを目指す動きも活発化しており、プラスチック廃棄物を削減し、医薬品製造の持続可能性を高めるために、リサイクル可能で生分解性のあるバイオプロセスバッグの素材が検討されています。

バイオプロセスバッグ市場の将来を形作る主な成長促進要因とは？

バイオプロセスバッグ市場の成長は、バイオ医薬品需要の増加、シングルユース技術の進歩、医薬品製造における無菌性向上の必要性など、いくつかの重要な要因によってもたらされます。最も重要な成長要因の一つは、モノクローナル抗体、組換えタンパク質、細胞療法を含む生物学的製剤のパイプラインの拡大です。製薬会社が世界のヘルスケア需要に対応するために生産を拡大する中、バイオプロセスバッグの拡張性と無菌性の利点は、最新のバイオ製造に不可欠な要素となっています。

市場を形成するもう一つの重要な促進要因は、シングルユースシステムが提供するコスト効率と操作の柔軟性です。従来のステンレス製バイオリアクターに比べ、バイオプロセスバッグは大がかりな洗浄の必要性をなくし、交差汚染のリスクを低減し、製造施設におけるターンアラウンドタイムの短縮を可能にします。バイオプロセスにおける自動化とデジタル化の役割の高まりも市場の成長を後押ししており、スマートなバイオプロセスバッグはリアルタイムのデータモニタリングとプロセスの最適化を提供します。さらに、シングルユース・バイオプロセシング技術に対する規制当局の支援は、特にバイオ医薬品インフラが急速に発展している新興国市場において、より広範な採用を促しています。

材料科学、バイオプロセス自動化、持続可能なパッケージングにおける先進の進歩が業界を再構築し続ける中、高性能バイオプロセスバッグの需要は加速すると予想されます。無菌性を高め、プロセス効率を向上させ、柔軟な製造をサポートするバイオプロセスバッグは、世界の生物製剤製造の革新と効率化を促進し、バイオ医薬品とバイオテクノロジーセクターの重要な構成要素であり続けるでしょう。

セグメント

製品タイプ（2Dバイオプロセスバッグ, 3Dバイオプロセスバッグ,その他バッグとアクセサリー）;ワークフロープロセスタイプ（アップストリームプロセス,ダウンストリームプロセス,プロセス開発）;エンドユーザー（製薬会社およびバイオ製薬会社エンドユーザー, CMOおよびCROエンドユーザー,学術研究機関エンドユーザー）

調査対象企業の例

  • Avantor, Inc.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Corning, Inc.
  • Dow, Inc.
  • Entegris, Inc.
  • Kiefel GmbH
  • Meissner Filtration Products, Inc.
  • PROAnalytics, LLC
  • Saint-Gobain Life Sciences
  • Sartorius AG
  • Single Use Support GmbH
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29606

Global Bioprocess Bags Market to Reach US$11.6 Billion by 2030

The global market for Bioprocess Bags estimated at US$4.4 Billion in the year 2024, is expected to reach US$11.6 Billion by 2030, growing at a CAGR of 17.8% over the analysis period 2024-2030. 2D Bioprocess Bags, one of the segments analyzed in the report, is expected to record a 20.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth in the 3D Bioprocess Bags segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 16.7% CAGR

The Bioprocess Bags market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 16.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.7% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Global Bioprocess Bags Market - Key Trends & Drivers Summarized

Why Are Bioprocess Bags Revolutionizing the Biopharmaceutical and Biotechnology Sectors?

Bioprocess bags have become a cornerstone of modern biopharmaceutical manufacturing, playing a crucial role in ensuring sterility, efficiency, and scalability in drug production. These single-use bioprocessing bags, made from specialized polymer films, serve as containment solutions for cell culture, fermentation, media storage, and transportation of biological products. With the rapid expansion of biologics, including monoclonal antibodies, vaccines, gene therapies, and personalized medicine, the demand for high-performance bioprocess bags has surged. Biopharmaceutical companies are increasingly adopting these single-use solutions to eliminate contamination risks, reduce operational costs, and enhance flexibility in production.

The shift from traditional stainless-steel bioreactors to single-use systems has further propelled the growth of bioprocess bags. Unlike reusable systems that require extensive cleaning and validation, single-use bioprocess bags streamline operations, minimize downtime, and support faster changeovers in multi-product facilities. The rising demand for COVID-19 vaccines, along with advancements in cell and gene therapy manufacturing, has also accelerated the adoption of bioprocess bags across research institutions, contract manufacturing organizations (CMOs), and biotech firms. As bioprocessing continues to evolve, bioprocess bags are poised to play a crucial role in optimizing efficiency, sterility, and cost-effectiveness in biologics production.

How Are Technological Innovations Enhancing the Performance of Bioprocess Bags?

Significant advancements in material science, barrier protection, and bioprocessing technology have transformed the capabilities of bioprocess bags, making them more reliable and efficient for pharmaceutical applications. One of the most notable innovations in this space is the development of multi-layered polymer films that enhance durability, chemical resistance, and gas permeability control. These high-performance films, often made from polyethylene, ethylene vinyl alcohol (EVOH), and polyvinyl chloride (PVC), provide superior protection against leachables, extractables, and microbial contamination. Additionally, the incorporation of gamma-stable materials ensures that bioprocess bags maintain integrity even after sterilization processes, improving their usability in critical drug manufacturing steps.

Another major breakthrough in bioprocess bag technology is the integration of real-time monitoring and automation. Smart bioprocess bags equipped with embedded sensors can track pH, temperature, dissolved oxygen, and pressure levels, providing real-time data for process optimization. This advancement enhances quality control and reduces the risk of batch failures in biopharmaceutical production. Furthermore, innovations in bioprocess bag connectors, such as aseptic quick-connect systems and sterile welding technologies, are improving fluid transfer efficiency while maintaining sterility. The ongoing development of customized bioprocess bags tailored for specific biologics, including cell and gene therapy applications, is further expanding the versatility of these solutions in modern bioprocessing environments.

Which Market Trends Are Driving the Growth of Bioprocess Bags?

The global bioprocess bags market is experiencing significant growth, driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing. One of the most impactful trends shaping the industry is the shift toward flexible and modular bioprocessing facilities. As biopharma companies strive for greater agility and efficiency, single-use bioprocess bags are being integrated into modular cleanroom designs and hybrid manufacturing systems, reducing capital investments in stainless-steel equipment. The growing reliance on contract development and manufacturing organizations (CDMOs) has also contributed to market expansion, as these organizations prioritize scalable and cost-effective single-use bioprocessing solutions.

Another key trend driving demand for bioprocess bags is the rise of advanced therapies, including personalized medicine, regenerative medicine, and cell-based immunotherapies. The need for sterile, contamination-free environments is paramount in these high-value biologics, making single-use bioprocess bags a preferred choice for storage and transport. Additionally, the expansion of vaccine manufacturing, particularly mRNA and viral vector vaccines, has increased the demand for single-use bioprocess solutions that facilitate rapid production scaling. The push toward environmentally friendly bioprocessing is also gaining traction, with companies exploring recyclable and biodegradable bioprocess bag materials to reduce plastic waste and enhance sustainability in pharmaceutical manufacturing.

What Are the Key Growth Drivers Shaping the Future of the Bioprocess Bags Market?

The growth in the bioprocess bags market is driven by several critical factors, including the increasing demand for biopharmaceuticals, advancements in single-use technologies, and the need for improved sterility in drug manufacturing. One of the most significant growth drivers is the expanding pipeline of biologic drugs, including monoclonal antibodies, recombinant proteins, and cell therapies. As pharmaceutical companies ramp up production to meet global healthcare demands, the scalability and sterility advantages of bioprocess bags make them an essential component of modern biomanufacturing.

Another key driver shaping the market is the cost-efficiency and operational flexibility offered by single-use systems. Compared to traditional stainless-steel bioreactors, bioprocess bags eliminate the need for extensive cleaning, reduce cross-contamination risks, and enable faster turnaround times in manufacturing facilities. The growing role of automation and digitalization in bioprocessing is also fueling market growth, with smart bioprocess bags offering real-time data monitoring and process optimization. Additionally, regulatory support for single-use bioprocessing technologies is encouraging broader adoption, particularly in emerging markets where biopharmaceutical infrastructure is rapidly developing.

As advancements in material science, bioprocessing automation, and sustainable packaging continue to reshape the industry, the demand for high-performance bioprocess bags is expected to accelerate. With their ability to enhance sterility, improve process efficiency, and support flexible manufacturing, bioprocess bags are set to remain a vital component of the biopharmaceutical and biotechnology sectors, driving innovation and efficiency in global biologics production.

SCOPE OF STUDY:

The report analyzes the Bioprocess Bags market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags and Accessories); Workflow Process Type (Upstream Process, Downstream Process, Process Development); End-Use (Pharmaceutical and Biopharmaceutical Companies End-Use, CMOs and CROs End-Use, Academic and Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Avantor, Inc.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Corning, Inc.
  • Dow, Inc.
  • Entegris, Inc.
  • Kiefel GmbH
  • Meissner Filtration Products, Inc.
  • PROAnalytics, LLC
  • Saint-Gobain Life Sciences
  • Sartorius AG
  • Single Use Support GmbH
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bioprocess Bags - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Growth in Biopharmaceutical Manufacturing Throws the Spotlight on Bioprocess Bags as Critical Single-Use Components
    • Shift Toward Flexible Manufacturing Platforms Drives Adoption of Disposable Bioprocessing Technologies
    • Rising Demand for Single-Use Solutions in Upstream and Downstream Processes Expands Addressable Market for Bioprocess Bags
    • Increasing Complexity of Biologics and Cell-Based Therapies Strengthens the Business Case for Customizable Bioprocess Bags
    • Accelerated Vaccine Development and Pandemic Preparedness Initiatives Propel Demand for Scalable Bag-Based Systems
    • Growth of Contract Manufacturing Organizations (CMOs) and CDMOs Fuels Market Demand for Ready-to-Deploy, Disposable Bioreactor Bags
    • Focus on Cross-Contamination Prevention and Batch-to-Batch Consistency Drives Single-Use System Adoption
    • Technological Advancements in Multi-Layer Films and Barrier Properties Enhance Bag Durability and Compatibility
    • Expansion of Cell and Gene Therapy Pipelines Creates New Application Opportunities for Bioprocess Bags in Aseptic Processing
    • Increased Utilization in Media Storage, Buffer Preparation, and Harvesting Processes Sustains Demand Across Bioproduction Stages
    • Integration of Smart Sensors and Bag Monitoring Technologies Throws the Spotlight on Intelligent Bioprocessing Bags
    • Eco-Friendly and Recyclable Alternatives Gain Momentum Amid Sustainability Pressures in Biopharma Manufacturing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bioprocess Bags Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for 2D Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for 2D Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for 3D Bioprocess Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for 3D Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Bags & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Bags & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Upstream Process by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Upstream Process by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Downstream Process by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Downstream Process by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Process Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Process Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharmaceutical & Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • JAPAN
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • CHINA
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • EUROPE
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Bioprocess Bags by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • FRANCE
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • GERMANY
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • UNITED KINGDOM
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Bioprocess Bags Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by Product Type - 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Bioprocess Bags by Product Type - Percentage Breakdown of Value Sales for 2D Bioprocess Bags, 3D Bioprocess Bags and Other Bags & Accessories for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by Workflow Process Type - Upstream Process, Downstream Process and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Bioprocess Bags by Workflow Process Type - Percentage Breakdown of Value Sales for Upstream Process, Downstream Process and Process Development for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Bioprocess Bags by End-Use - Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Bioprocess Bags by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030

IV. COMPETITION